+987.9%
MRNA vs ALLY
+4.2%
+983.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALLY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.8% | +9.3% | +11.8% |
| 7D | +20.6% | +2.4% | +18.3% | +19.7% |
| 30D | +27.1% | +5.6% | +21.6% | +24.6% |
| 3M | +353.4% | -11.7% | +365.1% | +377.1% |
| 6M | +446.3% | -7.0% | +453.3% | +457.3% |
| YTD | +776.2% | -10.4% | +786.6% | +822.4% |
| 1Y | +987.9% | +2.4% | +985.5% | +947.3% |
| All | +987.9% | +4.2% | +983.7% | +947.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLY.
Daily Out/Under-Performance
Portfolio return minus ALLY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALLY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling